Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction
- 24 September 2021
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1508 (1), 3-22
- https://doi.org/10.1111/nyas.14688
Abstract
Recent attention has focused on the growing role of psychostimulants, such as methamphetamine in overdose deaths. Methamphetamine is an addictive and potent stimulant, and its use is associated with a range of physical and mental health harms, overdose, and mortality. Adding to the complexity of this resurgent methamphetamine threat is the reality that the increases in methamphetamine availability and harms are occurring in the midst of and intertwined with the ongoing opioid overdose crisis. Opioid involvement in psychostimulant-involved overdose deaths increased from 34.5% of overdose deaths in 2010 to 53.5% in 2019—an increase of more than 50%. This latest evolution of the nation's overdose epidemic poses novel challenges for prevention, treatment, and harm reduction. This narrative review synthesizes what is known about changing patterns of methamphetamine use with and without opioids in the United States, other characteristics associated with methamphetamine use, the contributions of the changing illicit drug supply to use patterns and overdose risk, motivations for couse of methamphetamine and opioids, and awareness of exposure to opioids via the illicit methamphetamine supply. Finally, the review summarizes illustrative community and health system strategies and research opportunities to advance prevention, treatment, and harm reduction policies, programs, and practices.Keywords
This publication has 96 references indexed in Scilit:
- Preclinical characterization of an anti-methamphetamine monoclonal antibody for human usemAbs, 2013
- A New Survey of Methamphetamine Users in Treatment: Who They are, Why They Like “Meth,” and Why They Need Additional ServicesSubstance Use & Misuse, 2013
- An evolving problem: Methamphetamine production and trafficking in the United StatesInternational Journal of Drug Policy, 2012
- Contingency management treatments: controversies and challengesAddiction, 2010
- Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for InterventionsCurrent HIV/AIDS Reports, 2010
- Increased Drug Use and STI Risk with Injection Drug Use Among HIV-Seronegative Heterosexual Methamphetamine UsersJournal of Psychoactive Drugs, 2010
- Theories of Addiction: Methamphetamine Users' Explanations for Continuing Drug Use and RelapseThe American Journal on Addictions, 2009
- Substance-Use Outcomes at 18 Months Past Baseline: The PROSPER Community–University Partnership TrialAmerican Journal of Preventive Medicine, 2007
- Long-term Effects of Universal Preventive Interventions on Methamphetamine Use Among AdolescentsArchives of Pediatrics & Adolescent Medicine, 2006
- Reasons for stimulant use among lation gay men in San Francisco: A comparison between methamphetamine and cocaine usersJournal of Urban Health, 2005